Conservative approach of a symptomatic carious immature permanent tooth using a tricalcium silicate cement (Biodentine): a case report

The restorative management of deep carious lesions and the preservation of pulp vitality of immature teeth present real challenges for dental practitioners. New tricalcium silicate cements are of interest in the treatment of such cases. This case describes the immediate management and the follow-up of an extensive carious lesion on an immature second right mandibular premolar. Following anesthesia and rubber dam isolation, the carious lesion was removed and a partial pulpotomy was performed. After obtaining hemostasis, the exposed pulp was covered with a tricalcium silicate cement (Biodentine, Septodont) and a glass ionomer cement (Fuji IX extra, GC Corp.) restoration was placed over the tricalcium silicate cement. A review appointment was arranged after seven days, where the tooth was asymptomatic with the patient reporting no pain during the intervening period. At both 3 and 6 mon follow up, it was noted that the tooth was vital, with normal responses to thermal tests. Radiographic examination of the tooth indicated dentin-bridge formation in the pulp chamber and the continuous root formation. This case report demonstrates a fast tissue response both at the pulpal and root dentin level. The use of tricalcium silicate cement should be considered as a conservative intervention in the treatment of symptomatic immature teeth.

[1]  Seok-Woo Chang Chemical characteristics of mineral trioxide aggregate and its hydration reaction , 2012, Restorative dentistry & endodontics.

[2]  B. Pellat,et al.  Effect of a Calcium-silicate-based Restorative Cement on Pulp Repair , 2012, Journal of dental research.

[3]  P. Laurent,et al.  Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp mineralization. , 2012, International endodontic journal.

[4]  M. Eghbal,et al.  One-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial , 2012, Clinical Oral Investigations.

[5]  G. Richard,et al.  Clinical evaluation of the performance and safety of a new dentine substitute, Biodentine, in the restoration of posterior teeth — a prospective study , 2012, Clinical Oral Investigations.

[6]  J. Andreasen,et al.  Will mineral trioxide aggregate replace calcium hydroxide in treating pulpal and periodontal healing complications subsequent to dental trauma? A review , 2012, BDJ.

[7]  P. Farge,et al.  Evaluation of mineral trioxide aggregate (MTA) versus calcium hydroxide cement (Dycal(®) ) in the formation of a dentine bridge: a randomised controlled trial. , 2012, International dental journal.

[8]  T. Okiji,et al.  Uptake of calcium and silicon released from calcium silicate-based endodontic materials into root canal dentine. , 2011, International endodontic journal.

[9]  J. Camilleri,et al.  Characterization and hydration kinetics of tricalcium silicate cement for use as a dental biomaterial. , 2011, Dental materials : official publication of the Academy of Dental Materials.

[10]  P. Dummer,et al.  Properties and applications of calcium hydroxide in endodontics and dental traumatology. , 2011, International endodontic journal.

[11]  B W Darvell,et al.  "MTA"-an Hydraulic Silicate Cement: review update and setting reaction. , 2011, Dental materials : official publication of the Academy of Dental Materials.

[12]  B. Grosgogeat,et al.  Impedance methodology: A new way to characterize the setting reaction of dental cements. , 2010, Dental materials : official publication of the Academy of Dental Materials.

[13]  M. Torabinejad,et al.  Mineral trioxide aggregate: a comprehensive literature review--Part III: Clinical applications, drawbacks, and mechanism of action. , 2010, Journal of endodontics.

[14]  M. Torabinejad,et al.  Mineral trioxide aggregate: a comprehensive literature review--part II: leakage and biocompatibility investigations. , 2010, Journal of endodontics.

[15]  Mahmoud Torabinejad,et al.  Mineral trioxide aggregate: a comprehensive literature review--Part I: chemical, physical, and antibacterial properties. , 2010, Journal of endodontics.

[16]  G. T. Huang,et al.  Apexification: the beginning of its end. , 2009, International endodontic journal.

[17]  M. Eghbal,et al.  MTA pulpotomy of human permanent molars with irreversible pulpitis. , 2009, Australian endodontic journal : the journal of the Australian Society of Endodontology Inc.

[18]  A. Reis,et al.  Evaluation of two mineral trioxide aggregate compounds as pulp-capping agents in human teeth. , 2009, International endodontic journal.

[19]  Seok-Woo Chang,et al.  Ingredients and cytotoxicity of MTA and 3 kinds of Portland cements , 2008 .

[20]  D. Witherspoon Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth. , 2008, Journal of endodontics.

[21]  D. Charlton,et al.  Mineral trioxide aggregate material use in endodontic treatment: a review of the literature. , 2008, Dental materials : official publication of the Academy of Dental Materials.

[22]  H. Duncan,et al.  Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial , 2007, BDJ.

[23]  A. Reis,et al.  Evaluation of Mineral Trioxide Aggregate and Calcium Hydroxide Cement as Pulp-capping Agents in Human Teeth Materials and Methods , 2007 .

[24]  W. Oh,et al.  Pulp response of mineral trioxide aggregate, calcium sulfate or calcium hydroxide , 2007 .

[25]  J. Camilleri,et al.  Mineral trioxide aggregate: a review of the constituents and biological properties of the material. , 2006, International endodontic journal.

[26]  D. Avery,et al.  Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis). , 2006, Pediatric dentistry.

[27]  G. Harris,et al.  Mineral trioxide aggregate pulpotomies: a case series outcomes assessment. , 2006, Journal of the American Dental Association.

[28]  C. Pameijer,et al.  Clinical and histological evaluation of white ProRoot MTA in direct pulp capping. , 2006, American journal of dentistry.

[29]  H. Dh,et al.  Quality guidelines for endodontic treatment: consensus report of the European Society of Endodontology. , 2006, International endodontic journal.

[30]  R. Weiger European Society of Endodontology , 2004 .

[31]  M. Ghanbariha,et al.  Mineral trioxide aggregate (MTA) and calcium hydroxide as pulp-capping agents in human teeth: a preliminary report. , 2003, International endodontic journal.